Sysmex Establishes a Subsidiary in Kenya
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) has announced the establishment of a new subsidiary, Sysmex East Africa Ltd., in Kenya to promote business expansion in emerging countries as part of the company’s growth strategy. Going forward, we will strengthen our sales and customer care systems in nine East African countries, including Kenya, by direct sales through our subsidiary.
This will enable us to expand our product portfolio, allowing us to better meet the needs and realities in East Africa, and to further accelerate our business expansion into the African market.
The African Continent accounts for approximately 18% of the world's population, and its population is expected to continue growing in the future. Furthermore, healthcare expenditure is also increasing steadily in line with economic growth, and further expansion of the healthcare market is expected. Sysmex established its first subsidiary in Africa in South Africa in 2006, followed by ones in Burkina Faso in 2013 and in Ghana in 2015, and then in Egypt in 2018, strengthening the company’s sales and customer care structures in the region.
This time around, Sysmex established a new subsidiary in Kenya in order to strengthen its business foundations in East Africa, a region expected to achieve high levels of market growth within Africa. Direct sales through local subsidiary will enable us to promote the introduction of products that meet the needs of local customers while also providing globally standardized, high-quality customer care and a stable supply of products.
Going forward, Sysmex will strengthen its sales and customer care structures, promoting market development that leads to improved medical quality, while contributing to the expansion of medical infrastructure and improved access to medical care in emerging and developing countries.
【Overview of the New Subsidiary】
- Name:
Sysmex East Africa Ltd.
- Location:
Nairobi, Republic of Kenya
- Representative:
Bongi Mageushe
- Established:
March 2025
- Capital:
2,000,000 EURO
- Capital supplied by:
Sysmex Europe SE
(Sysmex Europe SE is a wholly owned subsidiary of Sysmex Corporation.)
- Employees:
19 (expected as of the end of fiscal year 2025)
- Line of business:
Sales and provision of customer care for in vitro diagnostic instruments, reagents, and laboratory information systems
Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey." Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives. For more information about Sysmex, please visit www.sysmex.co.jp/en/.
- *"Healthcare journey" is a trademark of Sysmex Corporation, registered in Japan.
Follow us on social media for the latest updates
- *Information contained in the news is current as of the date of the announcement, but may be subject to change without prior notice.



